BioSpace5hOpinion
Opinion: Angelman Syndrome Race Heats Up Among Ionis, Ultragenyx and Neuren
Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...
Oncology Nurse Advisor5d
HD-MTX Found Safe and Effective for Younger Patients With PCNSL
High-dose methotrexate (HD-MTX) with the modified Bonn protocol including intrathecal therapy is effective for patients less than 65 years old with primary central nervous system lymphoma (PCNSL), ...
The American Journal of Managed Care3d
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature ...
Infectious Disease Advisor2d
ASRA Pain Medicine: Evidence-Based Risk Reduction for Surgical Site Infections
American Society of Regional Anesthesia and Pain Medicine guidelines highlight SSI prevention in regional anesthesia and ...
Biogen Inc. (BIIB) Management presents at Leerink Global Healthcare Conference 2025 (Transcript)
Leerink Global Healthcare Conference 2025 March 10, 2025 11:20 AM ETCompany ParticipantsAlisha Alaimo - President of ...